Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.bloomberg.com/press-releases/2022-03-28/clarity-s-us-based-cu-64-sar-bispsma-trial-in-prostate-cancer-opens-for-recruitment
Mar 28, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next